TRPC6 and muscular dystrophy: The overexpression of a dominant negative mutant of TRPC6 in mdx or sarcoglycan-deficient mouse models of muscular dystrophy mitigates the dystrophic phenotype by inhibiting SOCE through TRPC6 [184].